A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/43 (2006.01) A61K 9/28 (2006.01) A61K 31/424 (2006.01) A61P 31/04 (2006.01)
Patent
CA 2188496
A tablet formulation, being a medicament for oral administration for the treatment of bacterial infections, the tablet comprising a compacted mixture of 750-950 mg of amoxycillin and a quantity of clavulanate in a weight ratio amoxycillin:clavulanate between 6:1 to 8:1 inclusive, and having a film coating of polymers which can be applied by aqueous film coating techniques.
Formulation de comprimé constituant un médicament destiné à être administré oralement dans le traitement d'infections bactériennes, lequel comprimé comprend un mélange compact de 750 à 950 mg d'amoxycilline ainsi qu'une certaine quantité de clavulanate, le rapport de poids entre l'amoxycilline et le clavulanate se situant entre 6:1 et 8:1 compris, et il possède un enrobage d'un film à base de polymères, lequel peut être appliqué à l'aide de techniques d'enrobage par film aqueux.
Conley Creighton Pierce
Davidson Nigel Philip Mccreath
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Polymer coated tablet comprising amoxycillin and clavulanate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer coated tablet comprising amoxycillin and clavulanate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer coated tablet comprising amoxycillin and clavulanate will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2073955